Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
1997-6-16
|
pubmed:abstractText |
Effects of (R)-N-(quinuclidin-3-yl)-2-(1-methyl-1 H-indol-3-yl)-2-oxo-acetamide (RS-056812-198) on 5-HT3 receptors have been investigated in whole-cell voltage-clamped N1E-115 mouse neuroblastoma cells and on 5-HT3 receptors composed of either long (5-HT3R-Al) or short (5-HT3R-AS) subunits expressed in Xenopus laevis oocytes. In N1E-115 cells RS-056812-198 evokes small transient inward currents, which are completely and reversibly inhibited by the selective 5-HT3 receptor antagonist MDL 72222 and cross-desensitizes with the 5-hydroxytryptamine (5-HT)-evoked current. The concentration-effect curve of RS-056812-198 yields an EC50 of 18 nM and a maximum amplitude of 15% of the maximum 5-HT-evoked current. In contrast to its effects on N1E-115 cells, RS-056812-198 does not evoke an ion current on cloned 5-HT3 receptors expressed in Xenopus oocytes, but acts as an antagonist. For 5-HT3R-A1 receptors, the IC50 of RS-056812-198 is 0.4 nM. The results show that (I) RS-056812-198 is a high-affinity partial agonist on 5-HT3 receptors in N1E-115 cells, thus providing a valuable tool to study agonist-receptor interaction in more detail: (2) 5-HT3 receptors on N1E-115 cells differ from the homo-oligomeric 5-HT3 receptors expressed in Xenopus oocytes. Whether the difference is caused by differences in protein processing in the two preparations or by expression of additional, yet unidentified subunits in N1E-115 cells and consequent formation of hetero-oligomeric 5-HT3 receptors remains to be determined.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Quinuclidines,
http://linkedlifedata.com/resource/pubmed/chemical/RS 56812,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin, 5-HT3,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Receptor Agonists
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
322
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
229-33
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9098692-Animals,
pubmed-meshheading:9098692-Membrane Potentials,
pubmed-meshheading:9098692-Mice,
pubmed-meshheading:9098692-Quinuclidines,
pubmed-meshheading:9098692-Receptors, Serotonin,
pubmed-meshheading:9098692-Receptors, Serotonin, 5-HT3,
pubmed-meshheading:9098692-Recombinant Proteins,
pubmed-meshheading:9098692-Serotonin Antagonists,
pubmed-meshheading:9098692-Serotonin Receptor Agonists,
pubmed-meshheading:9098692-Tumor Cells, Cultured,
pubmed-meshheading:9098692-Xenopus laevis
|
pubmed:year |
1997
|
pubmed:articleTitle |
RS-056812-198: partial agonist on native and antagonist on cloned 5-HT3 receptors.
|
pubmed:affiliation |
Research Institute of Toxicology, Utrecht University, Netherlands. h.vanhooft@ritox.dgk.ruu.nl
|
pubmed:publicationType |
Journal Article
|